C19H25BN4O4
384.2 g/mol
Aktif Farmasötik İngredientTehlike
Bortezomib
Bortezomib
CAS179324-69-7
Kategori
Aktif Farmasötik İngredient
Bileşik Sınıfı
Peptit
Birincil Kullanım
Farmasötik ham madde
Bortezomib is a pharmaceutical raw material used in the manufacturing of active pharmaceutical ingredients. It is a complex organic compound featuring amide groups and two aromatic rings, with a boronic acid moiety that contributes to its distinct molecular structure.
pharmaceutical manufacturingresearch compound for oncology studies
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 179324-69-7
İlgili Bileşikler
ReferansAynı kategori
Caspofungin acetate
CAS179463-17-3
active pharmaceutical ingredient
ReferansAynı kategori
Prucalopride
CAS179474-81-8
serotonin 4 receptor agonist
ReferansAynı kategori
Prucalopride succinate
CAS179474-85-2
active pharmaceutical ingredient
ReferansAynı kategori
Amisulpride-d5 N-Oxide
CAS1794756-15-2
deuterated active pharmaceutical ingredient impurity
Referansstereoisomer of
B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid
CAS1132709-15-9
active pharmaceutical ingredient
Referanssame scaffold
N-(pyrazine-2-yl-carbonyl)-L-phenylalanine
CAS1093959-75-1
pharmaceutical impurity reference standard
Referanssame scaffold
N-(Pyrazinylcarbonyl)-L-phenylalanine
CAS114457-94-2
Pharmaceutical intermediate
Referanssame scaffold
5-methyl-N-[2-(4-sulfamoylphenyl)ethyl]pyrazine-2-carboxamide
CAS33288-71-0
pharmaceutical intermediate
Güvenlik Referansı
Tehlike
H300Fatal if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H361Suspected of damaging fertility or the unborn child
H372Causes damage to organs through prolonged or repeated exposure
H411Toxic to aquatic life with long lasting effects
Tanımlayıcılar
IUPAC Adı
[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid
InChIKey
GXJABQQUPOEUTA-RDJZCZTQSA-N
SMILES
B([C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
Eş Anlamlılar (43)
- BORUZU
- DPBA
- Bortezomib (JAN/USAN/INN)
- 341, PS
- 3mg0
- BORTEZOMIB HYDRATE
- BORTEZOMIB [MART.]
- Bortexomib
- Bortezomib
- Bortezomib (PS-341)
- Bortezomib (Standard)
- Bortezomib (Velcade)
- Bortezomib - Bio-X trade mark
- Bortezomib accord
- Bortezomib for Injection
- PROSCRIPT BORONIC ACID
- PS 341 (pharmaceutical)
- PS-341 [Bortezomib]
- Peptide boronate
- Ps 341
- Pyz-Phe-boroLeu
- Velcade
- Velcade (Millenium)
- Velcade (TN)
- bortezomibum
- radiciol